The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension
Starting soon · Not applicable
Conditions studied: Hypertension
In brief
The goal of this pre-post study is to assess the risk of hyperkalemia in adults with hypertension on medication in Bangladesh. The main questions it aims to answer are: Is the risk of hyperkalemia after the initiation of Low Sodium Salt Substitute (LSSS) in people on antihypertensive medication (especially RASi) large enough to be concerned about its broad use in this population? Does initiation of LSSS correct hypokalemia in people on antihypertensive medication (especially RASi) with low serum potassium levels? Participants will be asked to reduce overall salt intake and to use LSSS on every occasion where regular salt would normally be used, including as cooking salt.
Key facts
- Study ID
- NCT07460882
- Run by
- Johns Hopkins University
- People needed
- 607
- Starts
- 2026-08-15
- Expected to finish
- 2027-09-30
- Last updated by the study team
- 2026-07-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults ≥18 years with clinically diagnosed hypertension treated with medication [on a stable dose at least for 2 months]
- Have a phone for contact
You may not qualify if…
- Those with baseline K ≥5.0 or K <3.0 mmol/L
- Advanced kidney disease (eGFR <45 ml/min/1.73m2).
- Those on potassium sparing diuretics (e.g., spironolactone)
- Other medical conditions determined by physicians (e.g., heart failure treated with medication; life expectancy less than 12 months)
- Dine out for dinner more than 3 times a week
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.